Teyro Labs Company Profile
✉ Email this page to a colleague
What is the competitive landscape for TEYRO LABS, and what generic and branded alternatives to TEYRO LABS drugs are available?
TEYRO LABS has four approved drugs.
Summary for Teyro Labs
| US Patents: | 0 |
| Tradenames: | 4 |
| Ingredients: | 4 |
| NDAs: | 4 |
Drugs and US Patents for Teyro Labs
| Applicant | Tradename | Generic Name | Dosage | NDA | Approval Date | TE | Type | RLD | RS | Patent No. | Patent Expiration | Product | Substance | Delist Req. | Exclusivity Expiration |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Teyro Labs | CARBOPLATIN | carboplatin | INJECTABLE;INTRAVENOUS | 077861-001 | Jan 18, 2007 | AP | RX | No | No | ⤷ Subscribe | ⤷ Subscribe | ||||
| Teyro Labs | CARBOPLATIN | carboplatin | INJECTABLE;INTRAVENOUS | 077861-002 | Jan 18, 2007 | AP | RX | No | No | ⤷ Subscribe | ⤷ Subscribe | ||||
| Teyro Labs | GEMCITABINE HYDROCHLORIDE | gemcitabine hydrochloride | INJECTABLE;INJECTION | 078759-002 | Jul 25, 2011 | AP | RX | No | No | ⤷ Subscribe | ⤷ Subscribe | ||||
| Teyro Labs | CARBOPLATIN | carboplatin | INJECTABLE;INTRAVENOUS | 077861-004 | Jan 18, 2007 | AP | RX | No | No | ⤷ Subscribe | ⤷ Subscribe | ||||
| Teyro Labs | CAPECITABINE | capecitabine | TABLET;ORAL | 217237-002 | Oct 23, 2023 | AB | RX | No | No | ⤷ Subscribe | ⤷ Subscribe | ||||
| Teyro Labs | TOPOTECAN HYDROCHLORIDE | topotecan hydrochloride | INJECTABLE;INJECTION | 091199-001 | Dec 1, 2010 | AP | RX | No | No | ⤷ Subscribe | ⤷ Subscribe | ||||
| >Applicant | >Tradename | >Generic Name | >Dosage | >NDA | >Approval Date | >TE | >Type | >RLD | >RS | >Patent No. | >Patent Expiration | >Product | >Substance | >Delist Req. | >Exclusivity Expiration |
Similar Applicant Names
Applicants may be listed under multiple names.
Here is a list of applicants with similar names.
Here is a list of applicants with similar names.
